STOCK TITAN

Crescent Biopharma: Venrock reports 5.9% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Crescent Biopharma, Inc. (CBIO) shares are the subject of an amended ownership report in which seven reporting persons reported beneficial ownership of 2,228,641 ordinary shares, or 5.9%, as of September 30, 2026. The reporting persons are Venrock Healthcare Capital Partners III, L.P.; VHCP Co-Investment Holdings III, LLC; Venrock Healthcare Capital Partners EG, L.P.; VHCP Management III, LLC; VHCP Management EG, LLC; Nimish Shah; and Bong Y. Koh. Shah and Koh are identified as voting members of the management entities.

The percentage calculation uses 37,143,940 ordinary shares outstanding as of July 27, 2026, plus 437,554 ordinary shares subsequently issued upon exercise of pre-funded warrants by the reporting persons, and gives effect to pre-funded warrants.

Aggregate beneficial ownership 2,228,641 ordinary shares Reported as of September 30, 2026 by each reporting person as the same aggregate position.
Percentage of class 5.9% Reported as of September 30, 2026.
Ordinary shares outstanding 37,143,940 ordinary shares As of July 27, 2026; used in the ownership-percentage calculation.
Shares issued upon warrant exercise 437,554 ordinary shares Issued subsequently upon exercise of pre-funded warrants by the reporting persons; included in the ownership-percentage calculation.
Pre-funded warrants exercisable for shares Up to 19,628 ordinary shares Held by Venrock Healthcare Capital Partners III, L.P.
Pre-funded warrants exercisable for shares Up to 1,964 ordinary shares Held by VHCP Co-Investment Holdings III, LLC.
Pre-funded warrants exercisable for shares Up to 73,315 ordinary shares Held by Venrock Healthcare Capital Partners EG, L.P.
Pre-Funded Warrants technical
"Pre-Funded Warrants immediately exercisable for up to 19,628 ordinary shares"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
beneficially owned regulatory
"Aggregate Amount Beneficially Owned by Each Reporting Person"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Shared Voting Power regulatory
"Shared Voting Power 2,228,641.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
Shared Dispositive Power regulatory
"Shared Dispositive Power 2,228,641.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CBIO shares did the reporting persons beneficially own?

The reporting persons reported the same aggregate beneficial ownership of 2,228,641 ordinary shares, equal to 5.9% as of September 30, 2026. The reported ownership includes ordinary shares and pre-funded warrants immediately exercisable for additional ordinary shares.

How was the CBIO 5.9% ownership percentage calculated?

The calculation used 37,143,940 ordinary shares outstanding as of July 27, 2026, plus 437,554 ordinary shares issued subsequently upon exercise of pre-funded warrants by the reporting persons, and gave effect to pre-funded warrants.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





G2545C104

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Venrock Healthcare Capital Partners III, L.P.
Signature:/s/ Sherman G. Souther
Name/Title:By VHCP Management III, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory
Date:11/16/2026
VHCP Co-Investment Holdings III, LLC
Signature:/s/ Sherman G. Souther
Name/Title:By VHCP Management III, LLC, its Manager, By Sherman G. Souther, Authorized Signatory
Date:11/16/2026
Venrock Healthcare Capital Partners EG, L.P.
Signature:/s/ Sherman G. Souther
Name/Title:By VHCP Management EG, LLC, its General Partner, By Sherman G. Souther, Authorized Signatory
Date:11/16/2026
VHCP Management III, LLC
Signature:/s/ Sherman G. Souther
Name/Title:By Sherman G. Souther, Authorized Signatory
Date:11/16/2026
VHCP Management EG, LLC
Signature:/s/ Sherman G. Souther
Name/Title:By Sherman G. Souther, Authorized Signatory
Date:11/16/2026
Nimish Shah
Signature:/s/ Sherman G. Souther
Name/Title:By Sherman G. Souther, Attorney-in-fact
Date:11/16/2026
Bong Y. Koh
Signature:/s/ Sherman G. Souther
Name/Title:By Sherman G. Souther, Attorney-in-fact
Date:11/16/2026
Exhibit Information

Exhibit 24.1 Power of Attorney for Bong Y. Koh (incorporated by reference to Exhibit 24.1 to the Reporting Persons' Schedule 13G filed with the SEC on June 23, 2025). Exhibit 24.2 Power of Attorney for Nimish P. Shah (incorporated by reference to Exhibit 24.2 to the Reporting Persons' Schedule 13G filed with the SEC on June 23, 2025). Exhibit 99.1 Joint Filing Agreement (incorporated by reference to Exhibit 99.1 to the Reporting Persons' Schedule 13G filed with the SEC on June 23, 2025).

Keep reading